- Research works
- 70 ▲ 24% vs 2013–17
- Citations
- 5k 71.1 per fractional work
- Top-10% rate
- 13.8% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Curis (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.
Who are the top researchers at Curis (United States)?
Ranked on the composite score, Leslie Lee and Elizabeth Martinez lead among researchers whose main affiliation is Curis (United States).
- 1 Leslie Lee United States · #577,939 worldwide 60 citations · 18 works
- 2 Elizabeth Martinez United States · #1,457,179 worldwide 8 citations · 24 works
Which keywords describe research at Curis (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Stem Cells, Tumorigenesis, Development, Transcriptional Regulation, Gene Expression and Pancreatic Cancer.
- HIF-1
- Pattern Recognition Receptors
- Fibroblast Activation Protein
- Proteasome Inhibitors
- Classification
- Immunosuppression
- DNA Methylation
- Immunotherapy
- Chemotherapy
- Angiogenesis
- Rituximab
- Inflammation
- PROTACs
- Histone Deacetylases
- Tumor Microenvironment
- Pathway Inhibition
- Hedgehog Signaling
- Transcriptional Regulation
- Tumorigenesis
- Cancer
- Cancer Therapy
- Stem Cells
- Development
- Gene Expression
- Pancreatic Cancer
- Epigenetic Regulation
- HDAC Inhibitors
- BET Bromodomains
- PET Imaging
- Prognostic Factors
- Innate Immunity
- Lymphoma
- NF-?B Activation
- Targeted Therapy
- Histone Modification
- Cancer Progression
- Molecular Profiling
- Cell Death
- N-terminal Acetylation
- Therapeutic Targets
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy12▲ 26×7 topics
- Cancer9▲ 9.2×14 topics
- Stem Cells8▲ 36×6 topics
- Tumorigenesis7▲ 183×3 topics
- Development7▲ 29×4 topics
- Transcriptional Regulation7▲ 39×6 topics
- Gene Expression6▲ 14×4 topics
- Hedgehog Signaling6▲ 222×1 topic
- Pancreatic Cancer6▲ 69×2 topics
- Pathway Inhibition6▲ 455×1 topic
- Epigenetic Regulation6▲ 37×2 topics
- Tumor Microenvironment6▲ 23×5 topics
- HDAC Inhibitors6▲ 408×1 topic
- Histone Deacetylases6▲ 408×1 topic
- BET Bromodomains5▲ 341×1 topic
- PROTACs5▲ 341×1 topic
- PET Imaging4▲ 28×3 topics
- Inflammation4▲ 2.5×17 topics
- Prognostic Factors3▲ 11×5 topics
- Rituximab3▲ 29×2 topics
- Innate Immunity3▲ 11×4 topics
- Angiogenesis3▲ 8.9×4 topics
- Lymphoma3▲ 25×2 topics
- Chemotherapy2▲ 4.8×6 topics
- NF-?B Activation2▲ 64×2 topics
- Immunotherapy2▲ 5.0×9 topics
- Targeted Therapy2▲ 14×3 topics
- DNA Methylation2▲ 24×1 topic
- Histone Modification2▲ 43×1 topic
- Immunosuppression2▲ 24×2 topics
- Cancer Progression2▲ 12×6 topics
- Classification2▲ 7.3×1 topic
- Molecular Profiling2▲ 22×1 topic
- Proteasome Inhibitors2▲ 39×2 topics
- Cell Death2▲ 13×4 topics
- Fibroblast Activation Protein2▲ 51×1 topic
- N-terminal Acetylation2▲ 51×1 topic
- Pattern Recognition Receptors2▲ 17×2 topics
- Therapeutic Targets2▲ 10×2 topics
- HIF-12▲ 32×1 topic
Which research topics does Curis (United States) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 2 Acute Myeloid Leukemia Research Hematology 1 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 5 CAR-T cell therapy research Oncology 0 works
- 6 Cytokine Signaling Pathways and Interactions Oncology 0 works
- 7 Immune Response and Inflammation Immunology 0 works
- 8 Glioma Diagnosis and Treatment Genetics 0 works
- 9 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
- 10 Inflammatory mediators and NSAID effects Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Curis (United States)'s research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lexington
- MIT Lincoln Laboratory
- Institute for Learning and Development
- Atmospheric and Environmental Research
- Inotek Pharmaceuticals (United States)
- Biostatistical Consulting (United States)
- Cubist Pharmaceuticals (United States)
- Ocean Acoustical Services and Instrumentation Systems (United States)
- Boston Collaborative Drug Surveillance Program
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.